9 Blockbuster Drugs Making Their Debut In 2017; Total Revenue Expected To Be $16B By 2021

It is always interesting to see what analysts believe the big new drugs of the year are going to be worth 5 years down the road and Clarivate Analytics has listed the 9 blockbusters their analysts expect to see approved by the FDA this year.